Corcept Therapeutics | Pasivo Circulante



Current Liabilities Cambio Fecha
Acadia Pharmaceuticals USD 302.53M 92.34M 2025-03
Alaunos Therapeutics USD 4K 822K 2024-10
ANI Pharmaceuticals USD 201.82M 8.14M 2025-03
Ardelyx USD 77.83M 7.33M 2024-12
Aurora Cannabis CAD 149.81M 40.71M 2024-12
BioMarin Pharmaceutical USD 628.21M 21.22M 2025-03
Bristol-Myers Squibb USD 24.07B 296M 2025-03
Canopy Growth CAD 97.02M 184.27M 2024-12
Corcept Therapeutics USD 143.07M 2.29M 2025-03
Eli Lilly USD 30.07B 1.69B 2025-03
J&J USD 56.9B 6.58B 2025-03
Knight Therapeutics CAD 118.15M 12.32M 2024-09
Merck USD 25.17B 3.25B 2025-03
Novartis USD 28.69B 560M 2024-12
Novartis USD 28.69B 560M 2024-12
Pacira USD 314.73M 4.81M 2025-03
Pfizer USD 36.45B 6.54B 2025-03
Supernus Pharmaceuticals USD 292.4M 889K 2024-12
TG Therapeutics USD 90.68M 34.43M 2024-12



Corcept Therapeutics Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.